Investments
16Portfolio Exits
4About Crabtree Ventures
Crabtree Ventures, L.P. is a $15 million early-stage venture capital fund targeted at applications of mathematical ideas in the life sciences and other industries. In addition to making equity investments at the Series A & B rounds, Crabtree's General Partner provides strategy and business-building skills. Investments to date: Novasite Pharmaceuticals; Applied Molecular Evolution; Blue Heron Biotechnology; Confer Software; and Hynomics Corporation.
Crabtree Ventures Investments
16 Investments
Crabtree Ventures has made 16 investments. Their latest investment was in Minute Molecular as part of their Unattributed VC - II on November 11, 2019.
Crabtree Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
11/22/2019 | Unattributed VC - II | Minute Molecular | $0.8M | No | 1 | |
10/23/2018 | Series G - II | Biodesix | $17.51M | No | 2 | |
8/13/2018 | Unattributed VC | Minute Molecular | $1.09M | Yes | 1 | |
7/16/2018 | Series G | |||||
5/8/2018 | Convertible Note - III |
Date | 11/22/2019 | 10/23/2018 | 8/13/2018 | 7/16/2018 | 5/8/2018 |
|---|---|---|---|---|---|
Round | Unattributed VC - II | Series G - II | Unattributed VC | Series G | Convertible Note - III |
Company | Minute Molecular | Biodesix | Minute Molecular | ||
Amount | $0.8M | $17.51M | $1.09M | ||
New? | No | No | Yes | ||
Co-Investors | |||||
Sources | 1 | 2 | 1 |
Crabtree Ventures Portfolio Exits
4 Portfolio Exits
Crabtree Ventures has 4 portfolio exits. Their latest portfolio exit was Minute Molecular on May 11, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
5/11/2023 | Merger | 1 | |||
Date | 5/11/2023 | |||
|---|---|---|---|---|
Exit | Merger | |||
Companies | ||||
Valuation | ||||
Acquirer | ||||
Sources | 1 |
Loading...